Clinical Significance

Clinical significance, also called practical significance, is the judgment that an effect is large enough to matter in the real world, not merely large enough to be detected. The word clinical comes from medicine, where a drug might lower blood pressure by an amount so small no patient would ever feel it, yet a big enough trial can still prove the drop is real. Clinical significance asks the second, harder question. Is the change worth acting on? In marketing you meet the same split. A tested headline might lift conversion rate by a hundredth of a percentage point across millions of visitors, which is real, measurable, and far too small to justify a redesign. Clinical significance is about the size and usefulness of an effect, judged against what a decision actually requires.

The idea forces you to name a threshold before you read the result. What lift would change your plan? A one-cent drop in cost per acquisition rarely moves a budget, while a twenty-percent drop does. Clinical significance sets that bar in the units the business cares about, such as dollars, retained customers, or hours saved, and then asks whether the measured effect clears it. This matters because large samples make tiny effects statistically significant, and dashboards happily flag them in green. Without a practical threshold, teams chase differences that are genuine but trivial, spending real effort on changes no customer will ever notice. Naming the size that matters, and naming it in advance, keeps scarce attention on the effects that are actually worth the work.

The two kinds of significance answer different questions, and confusing them is the classic error. Statistical significance asks whether an observed effect is likely to be real rather than random noise, usually summarized by a p-value and a chosen cutoff. Clinical significance asks whether that real effect is big enough to matter. An effect can be statistically significant but clinically trivial, because with enough data even a microscopic difference passes the p-value test. It can also be clinically important but statistically uncertain, as when a promising twelve-percent lift measured on a small sample matters enormously yet fails the significance test for lack of data. The p-value speaks to reality. The effect size speaks to importance. One tells you the difference is probably there; the other tells you whether you should care.

This is why a p-value alone is a poor decision rule. Report the effect size and a confidence interval alongside it, and read all three together. A confidence interval of plus-two to plus-eighteen percent tells you the effect is real and plausibly large, while an interval of plus-0.1 to plus-0.3 percent tells you it is real and certainly small. In an A/B test, statistical significance says the winning variant probably beat the control, and clinical significance says whether the margin is worth shipping, retraining a team, or rebuilding a page. Good analysts refuse to stop at significant. They ask significant, and how much, because the magnitude, not the star on the dashboard, is what you spend money against.

Judging clinical significance well starts before the test. Decide, in business units, the smallest effect that would change your decision, the minimum detectable effect worth caring about, and design the study to measure it. That single step aligns statistics with strategy, because it sizes the sample, sets the stakes, and defines success in advance. Then, when results arrive, lead with the effect size and its interval, not the p-value. Translate the effect into consequences a stakeholder can feel, not a 0.4-point lift but roughly nine hundred more sign-ups a month, worth about this much. Where an effect is real but small, say so plainly and move on. The discipline protects limited attention for the changes that genuinely move the business, rather than the ones that merely turned a dashboard green.

The traps are familiar. Teams treat statistical significance as the finish line and ship trivial wins because a tool flagged them. They read a large p-value as proof of no effect when the study was simply too small to detect a meaningful one. They compare effects across metrics without converting to common business terms, so a big-sounding percentage on a rare event looks more important than it is. And they forget that on huge samples nearly everything is significant, which makes effect size the only honest arbiter. The remedy is constant. Set a practical threshold up front, report the magnitude and its uncertainty, and judge importance by what the number does in the world, not by whether it crossed a cutoff.

Clinical significance takes clinical from medicine, where a real treatment effect is weighed for whether it is large enough to help a patient, and applies the same practical test to any measured effect.

Etymology: source.

Search interest for this term over the last five years:

View interest-over-time on Google Trends →

Areas of marketing where clinical significance is a core concern: